US Bancorp DE cut its holdings in RXO, Inc. (NYSE:RXO - Free Report) by 71.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 12,043 shares of the company's stock after selling 30,480 shares during the period. US Bancorp DE's holdings in RXO were worth $287,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also modified their holdings of the company. Wilmington Savings Fund Society FSB acquired a new position in shares of RXO in the 3rd quarter valued at about $28,000. Blue Trust Inc. boosted its holdings in shares of RXO by 79.7% in the 4th quarter. Blue Trust Inc. now owns 1,150 shares of the company's stock valued at $27,000 after buying an additional 510 shares during the period. Nomura Asset Management Co. Ltd. boosted its holdings in shares of RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company's stock valued at $39,000 after buying an additional 570 shares during the period. Thurston Springer Miller Herd & Titak Inc. boosted its holdings in shares of RXO by 407.0% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company's stock valued at $43,000 after buying an additional 1,445 shares during the period. Finally, KBC Group NV boosted its holdings in shares of RXO by 28.1% in the 3rd quarter. KBC Group NV now owns 4,055 shares of the company's stock valued at $114,000 after buying an additional 890 shares during the period. 92.73% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
RXO has been the topic of several recent research reports. The Goldman Sachs Group cut their price objective on shares of RXO from $28.00 to $24.00 and set a "neutral" rating on the stock in a research report on Thursday, February 6th. Stifel Nicolaus cut their price objective on shares of RXO from $27.00 to $24.00 and set a "hold" rating on the stock in a research report on Thursday, February 6th. Jefferies Financial Group cut their price objective on shares of RXO from $33.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday, January 10th. Truist Financial initiated coverage on shares of RXO in a research report on Thursday. They issued a "buy" rating and a $24.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of RXO in a research report on Friday, March 7th. They issued a "hold" rating and a $19.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, RXO has an average rating of "Hold" and a consensus price target of $25.80.
Check Out Our Latest Stock Analysis on RXO
RXO Stock Performance
Shares of RXO opened at $18.24 on Friday. The firm's 50 day moving average is $22.68 and its 200-day moving average is $25.90. The stock has a market capitalization of $2.98 billion, a P/E ratio of -8.61, a P/E/G ratio of 4.55 and a beta of 1.67. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.26 and a quick ratio of 1.33. RXO, Inc. has a 12-month low of $17.50 and a 12-month high of $32.82.
RXO (NYSE:RXO - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. RXO had a negative net margin of 6.26% and a positive return on equity of 1.53%. Equities research analysts anticipate that RXO, Inc. will post 0.31 EPS for the current fiscal year.
About RXO
(
Free Report)
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider RXO, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RXO wasn't on the list.
While RXO currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
